Lv1
60 积分 2021-08-13 加入
Oral Muvalaplin for Lowering of Lipoprotein(a)
2小时前
已完结
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
2小时前
已完结
The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity
1个月前
已完结
The Journey of Antibody-Drug Conjugates: Lessons Learned from 40 Years of Development
1个月前
已关闭
NASH drug treatment development: challenges and lessons
4个月前
已完结
Overall survival in first-line HR+/HER2- advanced breast cancer in the era of CDK4/6 inhibitors
4个月前
已关闭
Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype
1年前
已关闭
A genome-wide transcriptomic analysis of protein-coding genes in human blood cells
3年前
已完结
Development, Screening, and Validation of Camelid-Derived Nanobodies for Neuroscience Research
3年前
已完结
皖公网安备34019202002308
